Daniel B. Jernigan, M.D., M.P.H., is the Deputy Director for Public Health Science and Surveillance at CDC. In this position, he is responsible for strengthening CDC’s scientific foundation by working across the Office of Science, the Office of Laboratory Science and Safety, the Center for Surveillance, Epidemiology, and Laboratory Services, and the National Center for Health Statistics. A primary focus of Dr. Jernigan’s role is to provide leadership for CDC’s Data Modernization Initiative and serve as an advisor to the CDC Director.
Previously, Dr. Jernigan served as director of the Influenza Division in CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), where he was responsible for oversight and direction of the approximately 320 people working to reduce the domestic and global burden of disease and death due to seasonal, zoonotic and pandemic influenza. Prior to his appointment, Dr. Jernigan served as deputy director of the Influenza Division from 2006 to 2014. Dr. Jernigan also served as an officer in the U.S. Public Health Service. He retired as a Captain in 2019 after 23 years in the Commissioned Corps.
Dr. Jernigan received an undergraduate degree from Duke University, a Doctor of Medicine from Baylor College of Medicine, and a Master of Public Health from the University of Texas. He is board-certified in Internal Medicine and has completed an additional residency in Preventive Medicine.
Dr. Jernigan joined the CDC’s Epidemic Intelligence Service in 1994 and worked in the Respiratory Diseases Branch on the prevention and control of bacterial respiratory pathogens. In 1996, he began serving on assignment from CDC to the Washington State Health Department as a medical epidemiologist and coordinator of national initiatives to improve surveillance for emerging infectious diseases. Dr. Jernigan became the chief of the Epidemiology Section in CDC’s Division of Healthcare Quality Promotion (DHQP) in 2001. In that role, he supervised numerous investigations and initiatives to characterize various hospital-acquired, device-associated, and antimicrobial-resistant pathogen issues. In 2006, Dr. Jernigan joined the Influenza Division as Deputy Director.
Dr. Jernigan has authored more than 100 peer-reviewed articles and book chapters on various emerging infectious diseases topics, and has supervised outbreak investigations of viral, bacterial, and fungal infections associated with emerging and antimicrobial-resistant pathogens. He has led epidemiology and surveillance teams for national and international responses, including the 2001 bioterrorism-related anthrax, the 2002 emergence of West Nile virus, the 2003 SARS epidemic, 2009 H1N1 pandemic influenza, Ebola, and the 2019 COVID-19 pandemic. During the 2009 H1N1 influenza pandemic, Dr. Jernigan served as the CDC lead for all domestic and international epidemiology and laboratory activities for the U.S. government’s response. In 2015, Dr. Jernigan served as the incident manager for the CDC’s global Ebola response and in 2020 served as the incident manager for the CDC’s COVID-19 domestic and global response.